EUVIMEDEUVIMED entdecken
Open Access

Costimulatory connections: CARMIL2 and CD28

Lawrence P Kane iD

Journal of Experimental Medicine · 2025

DOI: 10.1084/jem.20250896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Lawrence P Kane. Beteiligte Einrichtung: Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: CD28 Antigens, CARD Signaling Adaptor Proteins, Guanylate Cyclase. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this issue of JEM, Zhang et al. (https://doi.org/10.1084/jem.20250339) report that a gain-of-function mutation in CARMIL2, previously identified in patients, is sufficient to replace the contribution of CD28 to NF-κB activation and downstream effects in T cells, including in the setting of an anti-tumor response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD28 AntigensCARD Signaling Adaptor ProteinsGuanylate CyclaseHumansNF-kappa BT-LymphocytesAnimalsLymphocyte ActivationMutationSignal Transduction

Substanzen

CD28 AntigensNF-kappa BCARD Signaling Adaptor ProteinsCARD11 protein, humanGuanylate Cyclase

Autor:innen und Institutionen

  • Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.

ORCID-Profile: Lawrence P Kane

Zitieren

APA

Kane, L. P. (2025). Costimulatory connections: CARMIL2 and CD28. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250896

Vancouver

Kane LP. Costimulatory connections: CARMIL2 and CD28. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20250896

BibTeX
@article{Kane2025,
  author = {Kane, Lawrence P},
  title = {Costimulatory connections: CARMIL2 and CD28},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  doi = {10.1084/jem.20250896}
}
Kostenlos starten →